Literature DB >> 21899993

Pharmacokinetic, tissue distribution and excretion of ginsenoside-Rd in rodents.

Dong Sun1, Bing Wang, Ming Shi, Yun-Xia Zhang, Lin-Fu Zhou, Zhi-Rong Liu, Zhong-Liang Wu, Wen Jiang, Jun-Liang Han, Li-Ze Xiong, Gang Zhao.   

Abstract

Ginsenoside-Rd (GS-Rd) is one of the major active components of Panax ginseng, and was shown to have the protective effects against several insults. However, we still lack some basic knowledge of GS-Rd, including its pharmacokinetic, tissue distribution and excretion in vivo in experimental animal, such as mice and rats. In this study, HPLC and radioactive tracer assays were performed to determine pharmacokinetic, tissue distribution and excretion of GS-Rd in rodents. After intravascular administration with 20, 50 or 150 mg/kg GS-Rd, the dynamic changes of GS-Rd concentrations in plasma were consistent with a two-compartment model while the concentration of ³H-labeled GS-Rd was rapidly reached the peak in plasma, and distributed to various tissues, among which the highest concentration was observed in the lung.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899993     DOI: 10.1016/j.phymed.2011.08.061

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

Review 1.  Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd.

Authors:  Xiaoping Song; Lina Wang; Daidi Fan
Journal:  Biomolecules       Date:  2022-03-28

2.  Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1 signaling pathway.

Authors:  Xiaofeng Zeng; Juan Li; Zhen Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 3.  Biotransformation, Pharmacokinetics, and Pharmacological Activities of Ginsenoside Rd Against Multiple Diseases.

Authors:  Jing Li; Qingxia Huang; Yao Yao; Peng Ji; E Mingyao; Jinjin Chen; Zepeng Zhang; Hongyu Qi; Jiaqi Liu; Zhaoqiang Chen; Daqing Zhao; Lei Zhou; Xiangyan Li
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

4.  Recent methodology in ginseng analysis.

Authors:  Seung-Hoon Baek; Ok-Nam Bae; Jeong Hill Park
Journal:  J Ginseng Res       Date:  2012-04       Impact factor: 6.060

5.  Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway.

Authors:  Yang Wang; Xu Li; Xiaoliang Wang; Waynebond Lau; Yajing Wang; Yuan Xing; Xing Zhang; Xinliang Ma; Feng Gao
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

6.  Ginsenoside Rd attenuates mitochondrial permeability transition and cytochrome C release in isolated spinal cord mitochondria: involvement of kinase-mediated pathways.

Authors:  Jin-Song Zhou; Jiang-Feng Wang; Bao-Rong He; Yong-Sheng Cui; Xiang-Yi Fang; Jian-Long Ni; Jie Chen; Kun-Zheng Wang
Journal:  Int J Mol Sci       Date:  2014-06-03       Impact factor: 5.923

7.  Ginsenoside Rg1 Attenuates Cigarette Smoke-Induced Pulmonary Epithelial-Mesenchymal Transition via Inhibition of the TGF-β1/Smad Pathway.

Authors:  Sibin Guan; Weiguo Xu; Fengfeng Han; Wen Gu; Lin Song; Wenjing Ye; Qian Liu; Xuejun Guo
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.